A patent review of peptidylarginine deiminase 4 (PAD4) inhibitors (2014–present)
Aiken SG. et al, (2025), Expert Opinion on Therapeutic Patents, 1 - 11
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent Inhibitor
O’Brien DP. et al, (2025), Journal of Proteome Research, 24, 479 - 490
Covalent Inhibitors of S100A4 Block the Formation of a Pro-Metastasis Non-Muscle Myosin 2A Complex
Giroud C. et al, (2024), Journal of Medicinal Chemistry
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors.
Ważyńska MA. et al, (2023), Journal of medicinal chemistry, 66, 9577 - 9591
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors
Schuller M. et al, (2023), Pathogens, 12, 324 - 324
Synthesis of meta-substituted arene bioisosteres from [3.1.1]propellane
Frank N. et al, (2022), Nature, 611, 721 - 726
Supported Gold Nanoparticle-Catalyzed Selective Reduction of Multifunctional, Aromatic Nitro Precursors into Amines and Synthesis of 3,4-Dihydroquinoxalin-2-Ones.
Iordanidou D. et al, (2022), Molecules (Basel, Switzerland), 27
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction
Shaabani S. et al, (2022), Molecules, 27
Author Correction: A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation
Nizami S. et al, (2021), Scientific Reports, 11
A phenotypic high-content, high-throughput screen identifies inhibitors of NLRP3 inflammasome activation
Nizami S. et al, (2021), Scientific Reports, 11
Nanoscale, automated, high throughput synthesis and screening for the accelerated discovery of protein modifiers
Gao K. et al, (2021), RSC Medicinal Chemistry, 12, 809 - 818
Multicomponent reaction–derived covalent inhibitor space
Sutanto F. et al, (2021), Science Advances, 7
Inhibition of the NLRP3 inflammasome by HSP90 inhibitors.
Nizami S. et al, (2021), Immunology, 162, 84 - 91
TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.
Kunig VBK. et al, (2020), Angewandte Chemie (International ed. in English), 59, 20338 - 20342
Multicomponent Reactions: "Kinderleicht"
Neochoritis CG. et al, (2020), Journal of Chemical Education, 97, 3739 - 3745
[18F]Atorvastatin: synthesis of a potential molecular imaging tool for the assessment of statin-related mechanisms of action
Clemente GS. et al, (2020), EJNMMI Research, 10
Late-Stage Copper-Catalyzed Radiofluorination of an Arylboronic Ester Derivative of Atorvastatin.
S Clemente G. et al, (2019), Molecules (Basel, Switzerland), 24